DK158990C - Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater - Google Patents

Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater

Info

Publication number
DK158990C
DK158990C DK015290A DK15290A DK158990C DK 158990 C DK158990 C DK 158990C DK 015290 A DK015290 A DK 015290A DK 15290 A DK15290 A DK 15290A DK 158990 C DK158990 C DK 158990C
Authority
DK
Denmark
Prior art keywords
derivatives
homovitamin
cholesta
stage
preparation
Prior art date
Application number
DK015290A
Other languages
English (en)
Other versions
DK15290A (da
DK158990B (da
DK15290D0 (da
Inventor
Hector F Deluca
Nubou Ikekawa
Yoko Tanaka
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of DK15290A publication Critical patent/DK15290A/da
Publication of DK15290D0 publication Critical patent/DK15290D0/da
Publication of DK158990B publication Critical patent/DK158990B/da
Application granted granted Critical
Publication of DK158990C publication Critical patent/DK158990C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK015290A 1984-10-04 1990-01-19 Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater DK158990C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65754984A 1984-10-04 1984-10-04
US65754984 1984-10-04
PCT/US1985/001571 WO1986002078A1 (en) 1984-10-04 1985-08-19 Vitamin d derivatives and methods for preparing same
US8501571 1985-08-19

Publications (4)

Publication Number Publication Date
DK15290A DK15290A (da) 1990-01-19
DK15290D0 DK15290D0 (da) 1990-01-19
DK158990B DK158990B (da) 1990-08-13
DK158990C true DK158990C (da) 1991-01-21

Family

ID=24637652

Family Applications (5)

Application Number Title Priority Date Filing Date
DK260086A DK154290C (da) 1984-10-04 1986-06-03 Vitamin-d-derivater og farmaceutiske praeparater indeholdende disse
DK111188A DK159389C (da) 1984-10-04 1988-03-02 Cholestadien- eller -trienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af 24-homovitamin-d3-derivater
DK177489A DK158989C (da) 1984-10-04 1989-04-13 Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
DK015390A DK158991C (da) 1984-10-04 1990-01-19 Cholestadienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater
DK015290A DK158990C (da) 1984-10-04 1990-01-19 Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DK260086A DK154290C (da) 1984-10-04 1986-06-03 Vitamin-d-derivater og farmaceutiske praeparater indeholdende disse
DK111188A DK159389C (da) 1984-10-04 1988-03-02 Cholestadien- eller -trienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af 24-homovitamin-d3-derivater
DK177489A DK158989C (da) 1984-10-04 1989-04-13 Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
DK015390A DK158991C (da) 1984-10-04 1990-01-19 Cholestadienderivater, der kan anvendes som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater

Country Status (13)

Country Link
EP (1) EP0197949A1 (da)
JP (3) JPS62500301A (da)
AU (2) AU582789B2 (da)
BE (1) BE903376A (da)
CH (1) CH672920A5 (da)
DE (2) DE3590488C2 (da)
DK (5) DK154290C (da)
FR (1) FR2571369B1 (da)
GB (2) GB2167070B (da)
IE (1) IE58104B1 (da)
IT (1) IT1190401B (da)
NL (1) NL8520265A (da)
WO (1) WO1986002078A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0144358B1 (ko) * 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
EP0374219A1 (en) * 1988-04-29 1990-06-27 Wisconsin Alumni Research Foundation SIDE CHAIN UNSATURATED 1$g(a)-HYDROXYVITAMIN D HOMOLOGS
GB2229921B (en) * 1989-04-05 1992-12-16 Chugai Pharmaceutical Co Ltd Treatment for hyperparathyroidism with use of vitamin d derivatives
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5891865A (en) * 1996-10-04 1999-04-06 Wisconsin Alumni Research Foundation Treatment of arthritic disease induced by infectious agents
AU2005303773A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
AU527805B2 (en) * 1978-07-27 1983-03-24 Research Institute For Medicine And Chemistry Inc. 1alpha, 1beta dihydroxy steroid-5-enes
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
US4448721A (en) * 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
DE3448360C2 (da) * 1983-05-09 1991-10-02 Wisconsin Alumni Res Found

Also Published As

Publication number Publication date
DK15290A (da) 1990-01-19
DK111188D0 (da) 1988-03-02
DE3590488C2 (da) 1992-10-01
AU2761488A (en) 1989-06-08
FR2571369A1 (fr) 1986-04-11
GB2188932B (en) 1988-09-01
DK111188A (da) 1988-03-02
CH672920A5 (da) 1990-01-15
DK154290B (da) 1988-10-31
AU605007B2 (en) 1991-01-03
DK159389B (da) 1990-10-08
JPH0569103B2 (da) 1993-09-30
DK159389C (da) 1991-03-11
GB2188932A (en) 1987-10-14
AU4776185A (en) 1986-04-17
JPH05178887A (ja) 1993-07-20
FR2571369B1 (fr) 1987-12-04
DK177489A (da) 1989-04-13
WO1986002078A1 (en) 1986-04-10
DK260086A (da) 1986-06-03
IE58104B1 (en) 1993-06-30
JPH0689022B2 (ja) 1994-11-09
DK15390A (da) 1990-01-19
IT1190401B (it) 1988-02-16
GB8709579D0 (en) 1987-05-28
JPS62500301A (ja) 1987-02-05
IT8522359A0 (it) 1985-10-04
DK158990B (da) 1990-08-13
IE852443L (en) 1986-04-04
BE903376A (fr) 1986-02-03
GB8524479D0 (en) 1985-11-06
DK158989C (da) 1991-01-21
GB2167070B (en) 1988-09-01
DK177489D0 (da) 1989-04-13
DE3590488T (de) 1986-10-09
AU582789B2 (en) 1989-04-13
DK158989B (da) 1990-08-13
DK15390D0 (da) 1990-01-19
DK158991B (da) 1990-08-13
EP0197949A1 (en) 1986-10-22
DK260086D0 (da) 1986-06-03
DK15290D0 (da) 1990-01-19
JPH0635475B2 (ja) 1994-05-11
JPH05222089A (ja) 1993-08-31
DK158991C (da) 1991-01-21
DK154290C (da) 1989-03-28
GB2167070A (en) 1986-05-21
NL8520265A (nl) 1986-09-01

Similar Documents

Publication Publication Date Title
IT8424009A0 (it) Composizioni analgesiche ed anti-infiammatorie migliorate, comprendente xantine e metodi di utilizzare le stesse.
DK159146C (da) Analogifremgangsmaade til fremstilling af 1,2-diaminocyclobuten-3,4-dioner og cyclobuten-3,4-dionderivater til anvendelse som mellemprodukter i fremgangsmaaden
NO842273L (no) Fremgangsmaate ved fremstilling av aminomethyloxooxazolidinylbenzenderivater.
DK153787C (da) Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
DK157031C (da) Fremgangsmaade til fremstilling af 4'-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf til anvendelse som udgangsmaterialer i fremgangsmaaden
NO20000265L (no) Kontrollerte cytolyser av mõlceller, midler og sammensetninger som forõrsaker cytolyse og forbindelser som kan anvendes for õ fremstille midlene
DK318088D0 (da) Vaeskeformig, vandig detergentsammensaetning og fremgangsmaade til fremstilling af samme
DK184588D0 (da) Mellemprodukter til brug ved fremstilling af 1alfa,25-dihydroxylerede vitamin d2-derivater
ES2016365B3 (es) Precursores diperoxiacidos, proceso para la produccion de los mismos y su uso en composiciones de blanqueo.
DK158989C (da) Cholestadienderivat, der kan anvendes som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
DK108780A (da) Fremgangsmaade til fremstilling af urinstofderivater disses anvendelse samt mellemprodukter til anvendelse ved fremstillingen
DK162394C (da) 26-homocholesta-5-en forbindelse, der kan anvendes som mellemprodukt til brug ved fremstillingen af 26-homovitamin d3 derivater
DK437287D0 (da) 2,3-dihydrofuranderivater, deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af tetrahydrofuranderivater
DK498284D0 (da) Fremgangsmaade til fremstilling af lignocelluloseholdige kompositgenstande.
DK157865C (da) Fremgangsmaade til fremstilling af ranitidin og ethyleniminoderivat til anvendelse som udgangsmateriale ved fremgangsmaaden
DK382183D0 (da) I 6-stilling usubstituerede 7-oxo-4-oxa-diazabicyclo(3.2.0)hept-2-en-derivater, fremgangsmader til deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af beta-lactamantibiotika
DK160987C (da) 9,10-dihydroxy-perhydroisoquinolinderivater til anvendelse som mellemprodukt ved fremstilling af 14-hydroxy-morphinanderivater
DK513888D0 (da) Fremgangsmaade til fremstilling af 2-(1-halogenalkyl)thiazol-forbindelser samt hidtil ukendte forbindelser, som kan fremstilles ved fremgangsmaaden
DK422582A (da) Oxiraner til anvendelse som mellemprodukter ved fremstilling af substituerede 1-azolyl-2-hydroxy-alkanderivater
DK422382A (da) Oxiraner til anvendelse som mellemprodukter ved fremstilling af substituerede 2-hydroxy-3-azolyl-propanderivater
DK155323C (da) D,1-6-oxo-4,5,6,7-tetrahydro-1h-(eller 2h)-indazol til brug som mellemprodukt ved fremstilling af tautomere aminosubstituerede 4,5,6,7-tetrahydro-1h-(eller 2h)-indazoler
DK135885D0 (da) Mellemprodukt egnet til anvendelse ved fremstilling af terbutalinderivater
DK153945C (da) Alkyl-3-acyl-1,2,3,4,4a,5,10,10a-octahydro-2,5-methanobenzo(g)quinolin-3-carboxylater til brug som mellemprodukter ved fremstilling af 11(eq)-(2-acylethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazociner, samt fremgangsmaade til fremstilling af de naevnte benzazociner
DK173285D0 (da) Organophosphorforbindelser, der kan anvendes som antikonvulsantmidler
DK144698C (da) 2,4-diamino-6-halogen-5-benzylpyrimidiner til anvendelse som mellemprodukter ved fremstilling af 2,4-diamino-5-benzylpyrimidiner